ソラフェニブ市場レポートタイプ別(特許医薬品、ジェネリック医薬品)、用途別(腎臓がん、肝臓がん、甲状腺がん)、地域別 2025-2033

ソラフェニブ市場レポートタイプ別(特許医薬品、ジェネリック医薬品)、用途別(腎臓がん、肝臓がん、甲状腺がん)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A26973

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Sorafenib Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Sorafenib Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Global Sorafenib Market - Breakup by Type
6.1 Patented Drugs

6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Generic Drugs
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Attractive Investment Proposition by Type

7 Global Sorafenib Market - Breakup by Application
7.1 Kidney Cancer

7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Liver Cancer
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Thyroid Cancer
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2019-2024)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2025-2033)
7.4 Attractive Investment Proposition by Application

8 Global Sorafenib Market – Breakup by Region
8.1 North America
8.1.1 United States

8.1.1.1 Market Drivers
8.1.1.2 Historical and Current Market Trends (2019-2024)
8.1.1.3 Market Breakup by Type
8.1.1.4 Market Breakup by Application
8.1.1.5 Key Players
8.1.1.6 Market Forecast (2025-2033)
8.1.2 Canada
8.1.2.1 Market Drivers
8.1.2.2 Historical and Current Market Trends (2019-2024)
8.1.2.3 Market Breakup by Type
8.1.2.4 Market Breakup by Application
8.1.2.5 Key Players
8.1.2.6 Market Forecast (2025-2033)
8.2 Europe
8.2.1 Germany

8.2.1.1 Market Drivers
8.2.1.2 Historical and Current Market Trends (2019-2024)
8.2.1.3 Market Breakup by Type
8.2.1.4 Market Breakup by Application
8.2.1.5 Key Players
8.2.1.6 Market Forecast (2025-2033)
8.2.2 France
8.2.2.1 Market Drivers
8.2.2.2 Historical and Current Market Trends (2019-2024)
8.2.2.3 Market Breakup by Type
8.2.2.4 Market Breakup by Application
8.2.2.5 Key Players
8.2.2.6 Market Forecast (2025-2033)
8.2.3 United Kingdom
8.2.3.1 Market Drivers
8.2.3.2 Historical and Current Market Trends (2019-2024)
8.2.3.3 Market Breakup by Type
8.2.3.4 Market Breakup by Application
8.2.3.5 Key Players
8.2.3.6 Market Forecast (2025-2033)
8.2.4 Italy
8.2.4.1 Market Drivers
8.2.4.2 Historical and Current Market Trends (2019-2024)
8.2.4.3 Market Breakup by Type
8.2.4.4 Market Breakup by Application
8.2.4.5 Key Players
8.2.4.6 Market Forecast (2025-2033)
8.2.5 Spain
8.2.5.1 Market Drivers
8.2.5.2 Historical and Current Market Trends (2019-2024)
8.2.5.3 Market Breakup by Type
8.2.5.4 Market Breakup by Application
8.2.5.5 Key Players
8.2.5.6 Market Forecast (2025-2033)
8.2.6 Others
8.2.6.1 Historical and Current Market Trends (2019-2024)
8.2.6.2 Market Forecast (2025-2033)
8.3 Asia Pacific
8.3.1 China

8.3.1.1 Market Drivers
8.3.1.2 Historical and Current Market Trends (2019-2024)
8.3.1.3 Market Breakup by Type
8.3.1.4 Market Breakup by Application
8.3.1.5 Key Players
8.3.1.6 Market Forecast (2025-2033)
8.3.2 Japan
8.3.2.1 Market Drivers
8.3.2.2 Historical and Current Market Trends (2019-2024)
8.3.2.3 Market Breakup by Type
8.3.2.4 Market Breakup by Application
8.3.2.5 Key Players
8.3.2.6 Market Forecast (2025-2033)
8.3.3 India
8.3.3.1 Market Drivers
8.3.3.2 Historical and Current Market Trends (2019-2024)
8.3.3.3 Market Breakup by Type
8.3.3.4 Market Breakup by Application
8.3.3.5 Key Players
8.3.3.6 Market Forecast (2025-2033)
8.3.4 South Korea
8.3.4.1 Market Drivers
8.3.4.2 Historical and Current Market Trends (2019-2024)
8.3.4.3 Market Breakup by Type
8.3.4.4 Market Breakup by Application
8.3.4.5 Key Players
8.3.4.6 Market Forecast (2025-2033)
8.3.5 Australia
8.3.5.1 Market Drivers
8.3.5.2 Historical and Current Market Trends (2019-2024)
8.3.5.3 Market Breakup by Type
8.3.5.4 Market Breakup by Application
8.3.5.5 Key Players
8.3.5.6 Market Forecast (2025-2033)
8.3.6 Indonesia
8.3.6.1 Market Drivers
8.3.6.2 Historical and Current Market Trends (2019-2024)
8.3.6.3 Market Breakup by Type
8.3.6.4 Market Breakup by Application
8.3.6.5 Key Players
8.3.6.6 Market Forecast (2025-2033)
8.3.7 Others
8.3.7.1 Historical and Current Market Trends (2019-2024)
8.3.7.2 Market Forecast (2025-2033)
8.4 Latin America
8.4.1 Brazil

8.4.1.1 Market Drivers
8.4.1.2 Historical and Current Market Trends (2019-2024)
8.4.1.3 Market Breakup by Type
8.4.1.4 Market Breakup by Application
8.4.1.5 Key Players
8.4.1.6 Market Forecast (2025-2033)
8.4.2 Mexico
8.4.2.1 Market Drivers
8.4.2.2 Historical and Current Market Trends (2019-2024)
8.4.2.3 Market Breakup by Type
8.4.2.4 Market Breakup by Application
8.4.2.5 Key Players
8.4.2.6 Market Forecast (2025-2033)
8.4.3 Others
8.4.3.1 Historical and Current Market Trends (2019-2024)
8.4.3.2 Market Forecast (2025-2033)
8.5 Middle East and Africa
8.5.1 Market Drivers
8.5.2 Historical and Current Market Trends (2019-2024)
8.5.3 Market Breakup by Type
8.5.4 Market Breakup by Application
8.5.5 Market Breakup by Country
8.5.6 Key Players
8.5.7 Market Forecast (2025-2033)
8.6 Attractive Investment Proposition by Region

9 Global Sorafenib Market – Competitive Landscape
9.1 Overview
9.2 Market Structure
9.3 Market Share by Key Players
9.4 Market Player Positioning
9.5 Top Winning Strategies
9.6 Competitive Dashboard
9.7 Company Evaluation Quadrant

10 Profiles of Key Players
10.1 Bayer AG

10.1.1 Business Overview
10.1.2 Products Offered
10.1.3 Business Strategies
10.1.4 Financials
10.1.5 SWOT Analysis                                                                                              
10.1.6 Major News and Events
10.2 Cipla Limited
10.2.1 Business Overview
10.2.2 Products Offered
10.2.3 Business Strategies
10.2.4 SWOT Analysis                                                      
10.2.5 Major News and Events
10.3 Hetero Healthcare Limited
10.3.1 Business Overview                                                                                                            
10.3.2 Products Offered
10.3.3 Business Strategies
10.3.4 SWOT Analysis                                     
10.3.5 Major News and Events
10.4 NATCO Pharma Limited
10.4.1 Business Overview
10.4.2 Products Offered
10.4.3 Business Strategies
10.4.4 Financials                                                                                  
10.4.5 SWOT Analysis
10.4.6 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
 
11 Global Sorafenib Market - Industry Analysis
11.1 Drivers, Restraints, and Opportunities

11.1.1    Overview
11.1.2    Drivers
11.1.3    Restraints
11.1.4    Opportunities
11.1.5    Impact Analysis
11.2   Porters Five Forces Analysis
11.2.1    Overview
11.2.2    Bargaining Power of Buyers
11.2.3    Bargaining Power of Suppliers
11.2.4    Degree of Competition
11.2.5    Threat of New Entrants
11.2.6    Threat of Substitutes
11.3 Value Chain Analysis

12 Strategic Recommendations

13 Appendix

ソラフェニブ市場レポートタイプ別(特許医薬品、ジェネリック医薬品)、用途別(腎臓がん、肝臓がん、甲状腺がん)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials